Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016

FromThe Lancet Respiratory Medicine in conversation with

Start listening View podcast show

Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016

FromThe Lancet Respiratory Medicine in conversation with

ratings:

Length:

11 minutes

Released:

Jul 26, 2016

Format:

Podcast episode

Description

Donald Tashkin discusses a clinical trial for the treatment of scleroderma-related interstitial lung disease, a rare but devastating condition.

Released:

Jul 26, 2016

Format:

Podcast episode

Titles in the series (100)

Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Respiratory Medicine: December 07, 2012 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: February 03, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: August 11, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: May 15, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
Cystic fibrosis detection and treatment: The Lancet Respiratory Medicine: August 10, 2016 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: March 05, 2013 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: December 23, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
Sepsis definitions: The Lancet Respiratory Medicine, February 22, 2016 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: June 04, 2013 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: April 07, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen
Interleukin 5: The Lancet Respiratory Medicine: March 23, 2015 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: December 17, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: August 20, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
11 min listen
The role of microbiome: The Lancet Respiratory Medicine: January 2016 by The Lancet Respiratory Medicine in conversation with
9 min listen
Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: October 22, 2013 by The Lancet Respiratory Medicine in conversation with
15 min listen
Fibrotic interstitial lung diseases: The Lancet Respiratory Medicine: May 12, 2015 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: January 27, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: July 19, 2013 by The Lancet Respiratory Medicine in conversation with
13 min listen
Air pollution and asthma: The Lancet Respiratory Medicine: Nov 12, 2015 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: October 25, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: March 24, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
Pleural disease: The Lancet Respiratory Medicine: July 6, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: April 10, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: June 25, 2014 by The Lancet Respiratory Medicine in conversation with
11 min listen
Life-support: The Lancet Respiratory: June 1, 2015 by The Lancet Respiratory Medicine in conversation with
33 min listen
The Lancet Respiratory Medicine: December 2, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: May 13, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen

More Episodes from The Lancet Respiratory Medicine in conversation with

Skip carousel

Eric Lim on treatments for pleural mesothelioma by The Lancet Respiratory Medicine in conversation with
6 min listen
Anne Chang on the burden of chronic respiratory diseases in Indigenous people by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID by The Lancet Respiratory Medicine in conversation with
8 min listen
Sarah Gorst and Tim Nicholson on long COVID outcomes by The Lancet Respiratory Medicine in conversation with
16 min listen
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Keith Chappell on a bivalent recombinant vaccine for COVID-19 by The Lancet Respiratory Medicine in conversation with
8 min listen
James Chalmers on bronchiectasis across Europe by The Lancet Respiratory Medicine in conversation with
12 min listen
Richard Costello on management of uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
12 min listen
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer by The Lancet Respiratory Medicine in conversation with
6 min listen
Carol Hodgson on post-discharge outcomes for ECMO patients by The Lancet Respiratory Medicine in conversation with
19 min listen
Emma Grainger on 10 years of The Lancet Respiratory Medicine by The Lancet Respiratory Medicine in conversation with
13 min listen
Vivienne Kahlmann and Catharina Moor on the TIRED study by The Lancet Respiratory Medicine in conversation with
9 min listen
Yves Lacasse on long-term oxygen therapy for COPD by The Lancet Respiratory Medicine in conversation with
17 min listen
Rachael Evans on living with long COVID by The Lancet Respiratory Medicine in conversation with
13 min listen
Daniel Munblit and Dale Needham on core outcomes post-COVID-19 by The Lancet Respiratory Medicine in conversation with
17 min listen
Daiana Stolz on antibiotic stewardship in pneumonia by The Lancet Respiratory Medicine in conversation with
10 min listen
Ablo Wachinou on sleep disordered breathing in Benin by The Lancet Respiratory Medicine in conversation with
11 min listen
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID by The Lancet Respiratory Medicine in conversation with
15 min listen
Dinh Bui on preterm birth and lung function deficits by The Lancet Respiratory Medicine in conversation with
6 min listen
Ruvim Izĭckson on a joint flu and COVID-19 vaccine by The Lancet Respiratory Medicine in conversation with
9 min listen
Wisia Wedzicha on a vaccine for COPD by The Lancet Respiratory Medicine in conversation with
9 min listen
Eileen Rubin on patient-centered ARDS by The Lancet Respiratory Medicine in conversation with
17 min listen
Daniel Altmann on COVID boosters by The Lancet Respiratory Medicine in conversation with
16 min listen
Michael Kreuter on interstitial lung disease by The Lancet Respiratory Medicine in conversation with
8 min listen
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Charles Sprung and authors on end-of-life practices in ICUs globally by The Lancet Respiratory Medicine in conversation with
16 min listen
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
13 min listen
Paul Verweij on COVID-19 associated aspergillosis by The Lancet Respiratory Medicine in conversation with
7 min listen
Ignacio Rubio on COVID-19 pathophysiology and phenotypes by The Lancet Respiratory Medicine in conversation with
9 min listen

Discover this podcast and so much more

Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016

Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016

Description

Titles in the series (100)

More Episodes from The Lancet Respiratory Medicine in conversation with